Sermorelin Ipamorelin Blend Dosage


Sermorelin Ipamorelin Blend Dosage


Sermorelin/Ipamorelin Blend Dosage



The blend of Sermorelin and Ipamorelin is typically administered via subcutaneous injection once or twice daily. A common starting dose is 0.2 mg of each peptide per injection, totaling 0.4 mg per day. For most individuals, the protocol involves a single morning injection; however, some protocols split the dose into a morning and evening administration to maintain stable hormone levels throughout the day. The duration of therapy can range from 12 weeks to several months, depending on the therapeutic goals such as growth hormone deficiency treatment, anti-aging, or athletic performance enhancement.




What is Sermorelin?



Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). It stimulates the pituitary gland to release natural human growth hormone (GH) by binding to GHRH receptors. Unlike direct GH therapy, Sermorelin encourages the body’s own production of GH, resulting in more physiologic secretion patterns and reduced risk of side effects like acromegaly or excessive fluid retention.




BENEFITS OF SERMORELIN:





Natural GH stimulation leading to improved tissue repair


Reduced water retention compared with exogenous GH


Lower risk of insulin resistance when used appropriately


Improved sleep architecture due to regulated GH pulses


Enhanced immune function through balanced cytokine release




What is Ipamorelin?



Ipamorelin is a selective growth hormone secretagogue that binds to ghrelin receptors (GHS-R1a) on pituitary somatotrophs. It induces the secretion of GH with minimal stimulation of prolactin or cortisol, making it a cleaner alternative to older secretagogues like GHRPs.